06/22/2017 - 3:20pm

Teva’s generic will be available in 75- and 150-mg dosage strengths.

06/22/2017 - 3:12pm

The Food and Drug Administration’s Drug Competition Action Plan begins with a public hearing on July 18 to assess the places where FDA regulations could be creating obstacles to generic access.

06/22/2017 - 1:26pm

Camber’s generic will be available in 20-, 40-, and 80-mg dosage strengths and packaged in 3x10 blister cards.

06/22/2017 - 10:32am

According to the CDC, American adults are behind on routine annual vaccinations.

06/20/2017 - 2:48pm

The company said that it’s expecting a launch in the second-half of 2017, and that it has already submitted an application to the FDA for a junior version of Symjepi.

06/20/2017 - 2:01pm

The drug is indicated as an adjunctive therapy to relieve discomfort associated with acute, painful musculoskeletal conditions.

06/20/2017 - 12:40pm

This launch marks the seventh product ANI has re-commercialized after acquiring a portfolio of discontinued generic abbreviated new drug applications. 

06/20/2017 - 10:30am

The company said that this marks its fourth first-to-market generic launch since June 2016.

06/20/2017 - 10:18am

The drug had U.S. sales of $15 million for the 12 months ended April 2017, Perrigo said.